Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.69 |
| ▸ | GSK3B | P49841 | 1/20 | 0.69 |
| ▸ | CCR6 | P51684 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL3504936 | 1.00 | GSK3A (0.69) | GSK3AGSK3BCCR6TSHR | |
| 1,4-Butanediol SCHEMBL28150883 | 0.88 | GSK3A (0.61) | GSK3AGSK3BCCR6 | |
| Acetic Acid SCHEMBL20637067 | 0.87 | GSK3A (0.52) | GSK3AGSK3BCCR6 | |
| Acetic Acid SCHEMBL28460657 | 0.87 | GSK3A (0.52) | GSK3AGSK3BCCR6 | |
| Alcohol SCHEMBL4116686 | 0.85 | GSK3A (0.65) | GSK3AGSK3BCCR6TSHR | |
| Di(Hydroxyethyl)Ether SCHEMBL16632726 | 0.84 | GSK3A (0.55) | GSK3AGSK3BCCR6TSHR | |
| Di(Hydroxyethyl)Ether SCHEMBL28982367 | 0.84 | GSK3A (0.55) | GSK3AGSK3BCCR6TSHR | |
| SCHEMBL7021498 | 0.83 | — | — | |
| SCHEMBL1599522 | 0.83 | — | — | |
| SCHEMBL10990 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2570 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117897400-A | Polyethylene glycol derivative modified interleukin 12 and preparation method and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-114196505-B | Rare cell capturing device and preparation method thereof | 江苏汇先医药技术有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-117603335-A | Human serum amyloid A mutant | 北京春雷杰创生物科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-116496511-A | Macroporous hydrogel with rapid degradation of enzyme response and preparation method and application thereof | 南京大学 | 2023-07-28 | — | — | CN | claimed |
| WO-2023106458-A1 | GENE CARRIER FOR ORAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DIABETES | 한국과학기술원 | 2023-06-15 | — | — | WO | claimed |
| CN-115382002-B | Sponge dressing with intelligent antibacterial and infection indication functions and preparation method thereof | 东华大学 | 2023-04-07 | — | — | CN | claimed |
| WO-2023051801-A1 | POLYETHYLENE GLYCOL DERIVATIVE MODIFIED INTERLEUKIN-12, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 康立泰生物医药(青岛)有限公司 | 2023-04-06 | — | — | WO | claimed |
| CN-115894660-A | Interleukin 12 modified by polyethylene glycol derivative, preparation method and application thereof | 康立泰生物医药(青岛)有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-115382002-A | Sponge dressing with intelligent antibacterial and infection indication functions and preparation method thereof | 东华大学 | 2022-11-25 | — | — | CN | claimed |
| CN-110494156-B | Hydrogel based on collagen and collagen-like peptides, corneal implant, filling cement and uses thereof | 熹微(苏州)生物医药科技有限公司 | 2022-11-22 | — | — | CN | claimed |
| US-20080076676-A1 | Novel construction of gold nanoparticle-based peptide chip, and assaying enzyme activity and inhibitor effect using secondary ion mass spectrometric analysis thereof | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-03-27 | — | — | US | claimed |
| CN-1871259-A | Improved antibodies having altered effector function and methods for making the same | BIOGEN IDEC INC (US) | 2006-11-29 | — | — | CN | claimed |
| EP-1711207-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | Medarex, Inc. (US) | 2006-10-18 | — | — | EP | claimed |
| WO-2005059106-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | MEDAREX, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| US-6410017-B1 | PERSONAL CARE WIPE COMPOSITION COMPRISING WATER INSOLUBLE SUBSTRATE, PLURALITY OF ACTIVE PROTEINS, AND BINDING MEANS, COMPRISING POLYMERIC TETHER, PERMANENTLY ATTACHING EACH ENZYME TO SUBSTRATE | THE PROCTER & GAMBLE COMPANY | 2002-06-25 | — | — | US | claimed |
| US-6303119-B1 | WIPES AND SKIN MASKS. | THE PROCTER & GAMBLE COMPANY | 2001-10-16 | — | — | US | claimed |
| EP-1115366-A2 | PERSONAL CARE COMPOSITIONS CONTAINING ACTIVE PROTEINS TETHERED TO A WATER INSOLUBLE SUBSTRATE | The Procter & Gamble Company (US) | 2001-07-18 | — | — | EP | claimed |
| EP-1115376-A1 | PERSONAL CARE COMPOSITIONS CONTAINING SUBTILISIN ENZYMES BOUND TO WATER INSOLUBLE SUBSTRATES | THE PROCTER & GAMBLE COMPANY (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2000016740-A1 | PERSONAL CARE COMPOSITIONS CONTAINING SUBTILISIN ENZYMES BOUND TO WATER INSOLUBLE SUBSTRATES | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-30 | — | — | WO | claimed |
| WO-2000016733-A2 | PERSONAL CARE COMPOSITIONS CONTAINING ACTIVE PROTEINS TETHERED TO A WATER INSOLUBLE SUBSTRATE | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-30 | — | — | WO | claimed |